It has been predicted that the COVID-19 pandemic would cause business disruption. Now, it has claimed a casualty with Second Sight Medical Products Inc., of Sylmar, Calif., which has been forced to wind down operations, citing the pandemic and the impact it will have on the companys ability to secure financing. Second Sight, which makes the Argus II retinal prosthesis system, said that effective March 31, 84 of its 108 employees will be laid off.
The company expects to bring on an adviser experienced in winding down operations to guide the board on next steps. However, additional layoffs are anticipated in the future based on the companys level of operations.
When asked whether it was looking for buyers for its Argus II/Orion assets and if it could predict how long the wind down would take, the company referred BioWorld to its statement and 8-K filing.
With the wind down announcement came news that the company had named Matthew Pfeffer, chairman of the audit committee of the board, as acting CEO, effective immediately. News of the companys winding down comes roughly three weeks after it reported that Will McGuire, president and CEO, was leaving, effective March 27. He was slated to remain as a director on Second Sights board.
McGuire left to join Carlsbad, Calif.-based Ra Medical Systems Inc. as CEO and a member of the companys board, effective March 30, citing the desire to be closer to his family.
With McGuires departure, Gregg Williams, the board chair, was tapped as acting CEO. However, now the company has decided to go with Pfeffer through this process.
Orion
Before the decision to wind down, the company had high hopes for its Orion visual cortical prosthesis system. The company saw the potential for the product to provide useful artificial vision to individuals blind from many causes, such as glaucoma, eye injury, diabetic retinopathy, optic nerve disease or injury and retinitis pigmentosa.
Indeed, during the companys March 19 fourth-quarter earnings call, COO Pat Ryan provided an update on the companys Orion early feasibility study. Specifically, it had wrapped up the 12-month testing for the sixth and final subject in February. Ryan detailed some results, noting that on square localization, 83% of individuals scored significantly better with the device on than off. All individuals scored significantly better with the device on than off on direction of motion.
From a safety perspective, as previously shared, there was one serious adverse event in seven nonserious adverse events over the same time period. These results are extremely encouraging, and we believe sufficient to support moving forward with a pivotal study in the U.S., Ryan said.
The company had reached an agreement with the U.S. FDA on the primary efficacy endpoint for the pivotal trial, which will be FLORA [Functional Low Vision Observer Rated Assessment] 20. As of that date, three of 15 subjects have begun participation in the FLORA 20 validation. However, due to COVID-19 social distancing protocols, we have suspended validation efforts until further notice, he said at the time.
Kyle Bauser from Dougherty & Co. asked whether COVID-19 had had an impact on the IDE application, given that it was now slated for the first half of next year. Ryan said no, adding that the company was being conservative in light of ongoing discussions with the FDA.
Competition
For its part, a big competitor of Second Sight, Paris-based Pixium Vision SA, reported March 31 positive follow-up data from a feasibility trial of the Prima system in patients with dry age-related macular degeneration (AMD). Specifically, the Prima system sustainably elicited light perception in all four dry AMD patients with favorable safety profile. The company said the results build on the previously reported positive 12-month clinical data. The Prima system is intended to partially replace the normal physiological function of the eyes photoreceptor cells by electrically stimulating the nerve cells of the inner retina. Those then transmit the visual information to the brain via the optic nerve.
But COVID-19 is having an impact on this company as well. Pixium reported March 23 that it had decided to postpone continuing its feasibility studies in France and the U.S., aside from ongoing safety monitoring. It added that the initiation of the PRIMAvera pivotal study with the Prima system in dry AMD may be delayed.
See the rest here:
Citing COVID-19, Second Sight to wind down operations - BioWorld Online
- Could my glasses be making my eyesight worse? - The Conversation - April 8th, 2024
- Eyeglasses Improve Income as Well as Sight, Study Shows - The New York Times - April 8th, 2024
- John Berger Lost His Eyesight to Cataracts and Learned to See - Hyperallergic - April 8th, 2024
- Eye Health Facts: What You Need to Know About the Eyes - Prevention Magazine - April 8th, 2024
- Reading glasses are good for your eyes and your income : Goats and Soda - NPR - April 8th, 2024
- 'The sight to fight:' Yorktown military members make thousands of glasses for the service - News 3 WTKR Norfolk - April 8th, 2024
- How to Watch the Solar Eclipse Without Damaging Your Eyes - Verywell Health - April 8th, 2024
- Protect Your Eyes While Watching the Solar EclipseExpert Advice from NYU Langone's Dr. Nitish Mehta - NYU Langone Health - April 8th, 2024
- 10 Daily Habits That Will Help You Protect Your Eye Health - CNET - January 25th, 2024
- Undergoing cataract surgery when it's not necessary? Some do it to improve their eyesight, but it's not without risk - The Conversation Indonesia - January 25th, 2024
- Sight Care Reviews - Is It Safe to Use? The Most Important Fact to Know Before Buy! - Kent Reporter - January 25th, 2024
- Apple has big and cartoonish plans for Vision Pro's EyeSight - AppleInsider - January 25th, 2024
- National Center for Children's Vision and Eye Health at Prevent Blindness Celebrates 15th Anniversary in 2024 - PR Web - January 25th, 2024
- Understanding Computer Vision Syndrome: Causes, Symptoms, and Practical Solutions - Medriva - January 25th, 2024
- 8 Eye Issues You Should Never Ignore - Right as Rain by UW Medicine - January 9th, 2024
- Digital eye strain is a growing issue as the muscles of the eyes work overtime, warn vision experts - Fox News - January 9th, 2024
- Know the Facts About Glaucoma - MedicineNet - January 9th, 2024
- New Year, New Vision: Top Resolutions For Optimal Eye Health - ABP Live - January 9th, 2024
- Childhood Myopia and Its Impact on Vision Loss: What Causes It? - News18 - January 9th, 2024
- What you see first in optical illusion can reveal a lot about you but youll need 20/20 vision to spot hi... - The Sun - January 9th, 2024
- The Importance of Eye Care: Preventing Vision Impairments and Maintaining Good Eye Health - Medriva - December 30th, 2023
- Six ways to look after your eyes in 2024 - The Conversation - December 30th, 2023
- 6 Essential Ways to Safeguard and Improve Your Vision in 2024 - Medriva - December 30th, 2023
- SightCare Reviews - Obvious Hoax or Safe Pills That Work? Fake Scams to Avoid | Courier-Herald - Enumclaw Courier-Herald - December 30th, 2023
- SightCare Reviews - Honest Customer Warning! Real Eyesight Support or Fake Hype? - Bothell-Kenmore Reporter - December 30th, 2023
- Global Intraocular Lens Market Surges with Innovations in Vision Correction | CAGR of 5.6% - PharmiWeb.com - December 30th, 2023
- Infection of the eye, and how to protect vision - The Hindu - December 30th, 2023
- Optical Illusion Eye Test: Can you find the dog in the street in 7 seconds? - Jagran Josh - December 30th, 2023
- You have 20/20 vision if you can find the hidden chick amongst these ducks - IndiaTimes - December 30th, 2023
- Eye Doc: Look *Here* While You Drive + 8 More Genius Tips to Improve Night Vision Behind The Wheel - Yahoo Life - December 22nd, 2023
- Designer creates inclusive clothing company after losing eyesight - Fox Business - December 22nd, 2023
- What is the state of American eyesight? - USAFacts - December 22nd, 2023
- When temporary vision loss in one eye isn't a sign of stroke - Harvard Health - December 22nd, 2023
- 10 Hacks That Can Naturally Boost Your Eye Health Today - CNET - December 22nd, 2023
- SightCare Reviews (Critical Customer Warning!) Know The Sight Care Facts Before Buy - Ukiah Daily Journal - December 22nd, 2023
- Everyone can spot the building with the hole in it but only those with 20/20 vision can find the giant C... - The US Sun - December 22nd, 2023
- Flashes, shimmers and blind spots: Here's what migraine aura looks like - The Washington Post - December 22nd, 2023
- Doctors Reveal the Snack That Cuts Your Risk of Vision-Clouding Cataracts in Half - Yahoo Life - December 22nd, 2023
- Yoga For Healthy Vision: 5 Extraordinary Yogasanas To Improve Eyesight - Netmeds.com - December 22nd, 2023
- Everyone can spot the teddy bears but you have 20/20 vision if you can see the bee in the bedroom in under... - The US Sun - December 22nd, 2023
- Reindeers blue eyes act as night vision goggles to help them find food in winter - The Guardian - December 22nd, 2023
- 6 Bad Habits That Could Be Damaging Your Eyesight - Money Talks News - December 22nd, 2023
- Reindeer vision may have evolved to spot favorite food in the snowy dark of winter - Phys.org - December 22nd, 2023
- Human eyes: How they work, and their amazing anatomy - BBC Science Focus Magazine - December 22nd, 2023
- Why reindeer eyes shine blue in the winter - The Washington Post - December 22nd, 2023
- Can Everyone Unfocus Their Eyes On Command? - IFLScience - December 22nd, 2023
- You have the eyes of a hunter if you can spot the dogs owner in the picture in 8 seconds! - Jagran Josh - December 22nd, 2023
- Everyone can see the Christmas trees but you could have 20/20 vision if you can spot the star hiding in t... - The US Sun - December 22nd, 2023
- Here's how eye exams can reveal several health conditions beyond your sight - The Record (New Westminster) - December 22nd, 2023
- At Bread for the Citys vision clinic, patients can see clearly now - The Washington Post - December 13th, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or Scam (2024) | Vashon-Maury Island Beachcomber - Vashon-Maury Island Beachcomber - December 13th, 2023
- The Benefits of Donning Prescription Sunglasses for Vision Correction and Protection - Anti Aging News - December 13th, 2023
- Vision Pro training of Apple retail store employees to start soon - BGR - December 13th, 2023
- 6 Best Vitamins and Supplements for Healthy Eyes - CNET - December 13th, 2023
- Eye Health: How to Protect Eyes From Digital Strain, Vision Loss and More? 5 Tips - India.com - December 13th, 2023
- How to watch the solar eclipse without damaging your eyesight - WATE 6 On Your Side - October 16th, 2023
- Can Optical Illusions Improve Vision? Know The Best One That Benefits Eyesight - Times Now - May 17th, 2023
- Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones - April 15th, 2023
- Revolution Medicines to Participate in 22nd Annual Needham Healthcare Conference - April 15th, 2023
- GENFIT Reports Full-Year 2022 Financial Results and Provides Corporate Update - April 15th, 2023
- Kane Biotech to Release Fourth Quarter and Full Year 2022 Financial Results on April 20, 2023 – Conference Call to Follow - April 15th, 2023
- Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting - April 15th, 2023
- Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference - April 15th, 2023
- Syneos Health Schedules First Quarter 2023 Earnings Call for Wednesday, May 10th, 2023 - April 15th, 2023
- Oncternal Therapeutics Participating in Oppenheimer & Co.’s Virtual Fireside Chat: Discussion of ROR1 CAR T Cell Therapy in Hematological... - April 15th, 2023
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 15th, 2023
- Alvotech Provides Regulatory Update on AVT02 Biologics License Application - April 15th, 2023
- Vivoryon Therapeutics N.V. to Report Full Year 2022 Financial Results and Operational Progress on April 19, 2023 - April 15th, 2023
- Additional Future Royalty Revenue Stream for Nicox from 2024 following New Drug Application Submission for ZERVIATE in China - April 15th, 2023
- Ultimovacs ASA – Disclosure of voting rights of Annual General Meeting - April 15th, 2023
- QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023 - April 15th, 2023
- ITM lädt zu Symposium und Messestand auf der Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin in Leipzig ein - April 15th, 2023
- International Carrot Day: From healthy eyesight to weight loss - 5 wonderful benefits of carrot - Zee Business - April 7th, 2023
- How the Human Eye Works | Cornea Layers/Role | Light Rays - NKCF.org - December 11th, 2022
- Eye Emergencies: Types, Symptoms, and Prevention - Healthline - November 25th, 2022
- The criteria for certification | RNIB - November 25th, 2022
- Foresight: Eye-Net Successfully Showcases its Advanced Solution to Leading OEMs and Tier One Suppliers in Japan - Marketscreener.com - November 25th, 2022
- Can you see me now? Average person begins worrying about their vision at age 39 - Study Finds - September 29th, 2022
- Contact lens wearers at higher risk of rare eye infection are you caring for your lenses the right way? - News24 - September 29th, 2022
- A man who popped a champagne cork into his eye says it felt like being poked 'times a thousand.' His vision was saved after months of treatment but it... - September 29th, 2022